Company Encyclopedia
View More
name
Entero Therapeutics
ENTO.US
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.
1.906 T
ENTO.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    GridAI Technologies Announces Board Changes and Rebranding

    GridAI Technologies Corp. announced board changes with the resignation of Eric Corbett and Richard Paolone. The company rebranded from Entero Therapeutics, Inc. to GridAI Technologies Corp., effective December 1, 2025, and updated its Nasdaq trading symbol to 'GRDX', reflecting a strategic shift towards AI technology.

    Tip Ranks·
    US
    ENTO
    0.00%
    Tip Ranks·
    US
    ENTO
    0.00%

    Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb

    Several small-cap biotech and healthcare stocks, including BioAtla, Entero, and Sonnet, posted notable gains in after-hours trading on November 28, 2025. BioAtla surged 13.94% following financing agreements, while Entero announced a rebranding to GridAI Technologies. Sonnet recovered after a decline, with strong support for a business combination deal. Other stocks like Metagenomi, PAVmed, Precision BioSciences, and Reviva Pharmaceuticals also saw gains, driven by investor sentiment and recent announcements.

    rttnews·
    US
    ENTO
    0.00%
    US
    BCAB
    +4.72%
    US
    SONN
    0.00%
    rttnews·
    US
    ENTO
    0.00%
    US
    BCAB
    +4.72%
    US
    SONN
    0.00%

    Entero Therapeutics Becomes GridAI Technologies

    Entero Therapeutics Inc. has changed its name to GridAI Technologies Corp. and will use the new ticker symbol "GRDX" after acquiring GRID AI Corp. This announcement was made on November 28, 2025, and the original content was published via ACCESS Newswire.

    Reuters·
    US
    ENTO
    0.00%
    US
    GRDX
    -2.24%
    Reuters·
    US
    ENTO
    0.00%
    US
    GRDX
    -2.24%

    Entero Therapeutics shares are trading lower. The company reported Q3 financial results.

    benzinga_article·
    US
    ENTO
    0.00%
    benzinga_article·
    US
    ENTO
    0.00%

    Entero Therapeutics | 10-Q: FY2025 Q3 Revenue: USD 0

    LB filings·
    US
    ENTO
    0.00%
    US
    GRDX
    -2.24%
    LB filings·
    US
    ENTO
    0.00%
    US
    GRDX
    -2.24%
    © 2025 Longbridge｜Disclaimer